High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$8.1M
$8,123,219
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$163,040
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $163,040 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$210,804
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $210,804 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$239,427
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $239,427 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$165,541
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $165,541 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$33,817
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $33,817 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$67,739
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $67,739 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$88,367
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $88,367 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$248,385
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $248,385 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$113,054
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $113,054 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$93,006
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $93,006 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$68,974
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $68,974 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$32,641
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $32,641 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-03
$101,142
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-03 | $101,142 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-03
$205,107
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-03 | $205,107 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-03
$148,854
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-03 | $148,854 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-03
$112,443
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-03 | $112,443 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$115,668
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $115,668 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$35,172
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $35,172 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$60,007
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $60,007 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$28,784
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $28,784 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$33,525
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $33,525 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$13,971
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $13,971 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$16,181
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $16,181 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$31,491
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $31,491 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$90,200
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $90,200 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$137,587
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $137,587 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-02-27
$41,773
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-02-27 | $41,773 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-02-27
$747,119
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-02-27 | $747,119 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-02-27
$384,197
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-02-27 | $384,197 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-02-27
$313,196
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-02-27 | $313,196 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-02-27
$46,815
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-02-27 | $46,815 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-02-13
$695,201
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-02-13 | $695,201 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$6,676
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $6,676 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$14,917
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $14,917 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$14,600
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $14,600 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$34,288
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $34,288 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$44,056
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $44,056 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$30,527
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $30,527 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$55,834
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $55,834 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$35,422
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $35,422 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$26,454
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $26,454 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$17,087
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $17,087 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$72,601
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $72,601 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$80,423
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $80,423 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$18,320
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $18,320 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$15,063
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $15,063 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$33,913
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $33,913 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$14,779
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $14,779 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$13,804
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $13,804 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$1,117
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $1,117 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$5,242
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $5,242 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$7,137
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $7,137 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$5,667
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $5,667 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2025-10-03
$97,690
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2025-10-03 | $97,690 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2025-10-03
$189,114
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2025-10-03 | $189,114 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2025-10-03
$405,680
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2025-10-03 | $405,680 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2025-10-03
$365,010
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2025-10-03 | $365,010 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2025-10-03
$306,893
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2025-10-03 | $306,893 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$1,373
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $1,373 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$67,242
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $67,242 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$33,275
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $33,275 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$110,981
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $110,981 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$149,290
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $149,290 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$302,397
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $302,397 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$150,018
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $150,018 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$243,888
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $243,888 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$111,998
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $111,998 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$80,779
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $80,779 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$25,084
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $25,084 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$51,351
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $51,351 | S | Form 4 |